FDA Schedules Vaccines Panel On COVID Boosters As Questions Linger About Data Adequacy

 
• By Sarah Karlin-Smith
third vaccine shot
FDA is moving fast to get Pfizer’s booster sBLA to an advisory committee just weeks after receiving the application • Source: Alamy

More from US FDA

More from Agency Leadership